Abstract:[Objective] To study the effects of the agonist and the antagonist of the purinergic P2X7 receptor on rat retinal ganglion cells (RGCs). [Methods] (1) Long-Evan neonatal rats were back labeled with Aminostilbamidine to identify RGCs. The effect of P2X7 receptor stimulation on RGCs cell viability was then examined using P2X7 receptor agonist BzATP (0, 50, 100, 500 ?滋mol/L) and antagonist OxATP (100 ?滋mol/L). (2) Retinal ganglion cells were dissociated from the retinas of unlabeled neonatal rats and were loaded with Fura-2, an intracellular calcium indicator. P2X7 agonist BzATP (50 ?滋mol/L), antagonist OxATP (100 ?滋mol/L ) were applied to RGCs to examine their effects on intracellular Ca2+ levels using Ca2+ imaging system. [Results] P2X7 receptor agonist BzATP killed RGCs in a concentration-dependent pattern with a EC50 of 35 ?滋M. Under the concentration of 50 ?滋mol/L, BzATP could kill about 30% of the RGCs. Cell death was prevented by P2X7 antagonists OxATP, increasing the cell viability from 77% ± 4% to 96% ±3% (P< 0.001). BzATP (50 ?滋mol/L) led to a large, sustained increases of intracellular Ca2+ (1022 ± 113 nmol/L). Calcium influx triggered by BzATP was attenuated by pre- and co-incubation of P2X7 antagonist OxATP with a slight increase of (63 ± 13) nmol/L (P< 0.001). [Conclusions] The activation of purinergic P2X7 receptor can cause rat retinal ganglion cell death and the increase of intracellular calcium.

An Experimental Study on Lethal Effect of P2X7 Receptor Activation on Rat Retinal Ganglion Cell